Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Flutamide (CAS 13311-84-7) Market Growth 2022-2028

  • LP 4916018
  • 94 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Flutamide (CAS 13311-84-7) will have significant change from previous year. According to our (LP Information) latest study, the global Flutamide (CAS 13311-84-7) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Flutamide (CAS 13311-84-7) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Flutamide (CAS 13311-84-7) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Flutamide (CAS 13311-84-7) market, reaching US$ million by the year 2028. As for the Europe Flutamide (CAS 13311-84-7) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Flutamide (CAS 13311-84-7) players cover Forward, Merck, Tasly Diyi Pharma, and Cipla LifeScience, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Flutamide (CAS 13311-84-7) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Flutamide Tablets

Flutamide Capsule

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Forward

Merck

Tasly Diyi Pharma

Cipla LifeScience

Actiza Pharma

TEVA Pharma

Florencia Healthcare

SANDOZ

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Flutamide (CAS 13311-84-7) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Flutamide (CAS 13311-84-7) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Flutamide (CAS 13311-84-7) by Country/Region, 2017, 2022 & 2028

2.2 Flutamide (CAS 13311-84-7) Segment by Type

2.2.1 Flutamide Tablets

2.2.2 Flutamide Capsule

2.2.3 Others

2.3 Flutamide (CAS 13311-84-7) Sales by Type

2.3.1 Global Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2022)

2.3.2 Global Flutamide (CAS 13311-84-7) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Flutamide (CAS 13311-84-7) Sale Price by Type (2017-2022)

2.4 Flutamide (CAS 13311-84-7) Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.5 Flutamide (CAS 13311-84-7) Sales by Application

2.5.1 Global Flutamide (CAS 13311-84-7) Sale Market Share by Application (2017-2022)

2.5.2 Global Flutamide (CAS 13311-84-7) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Flutamide (CAS 13311-84-7) Sale Price by Application (2017-2022)

3 Global Flutamide (CAS 13311-84-7) by Company

3.1 Global Flutamide (CAS 13311-84-7) Breakdown Data by Company

3.1.1 Global Flutamide (CAS 13311-84-7) Annual Sales by Company (2020-2022)

3.1.2 Global Flutamide (CAS 13311-84-7) Sales Market Share by Company (2020-2022)

3.2 Global Flutamide (CAS 13311-84-7) Annual Revenue by Company (2020-2022)

3.2.1 Global Flutamide (CAS 13311-84-7) Revenue by Company (2020-2022)

3.2.2 Global Flutamide (CAS 13311-84-7) Revenue Market Share by Company (2020-2022)

3.3 Global Flutamide (CAS 13311-84-7) Sale Price by Company

3.4 Key Manufacturers Flutamide (CAS 13311-84-7) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Flutamide (CAS 13311-84-7) Product Location Distribution

3.4.2 Players Flutamide (CAS 13311-84-7) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Flutamide (CAS 13311-84-7) by Geographic Region

4.1 World Historic Flutamide (CAS 13311-84-7) Market Size by Geographic Region (2017-2022)

4.1.1 Global Flutamide (CAS 13311-84-7) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Flutamide (CAS 13311-84-7) Annual Revenue by Geographic Region

4.2 World Historic Flutamide (CAS 13311-84-7) Market Size by Country/Region (2017-2022)

4.2.1 Global Flutamide (CAS 13311-84-7) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Flutamide (CAS 13311-84-7) Annual Revenue by Country/Region

4.3 Americas Flutamide (CAS 13311-84-7) Sales Growth

4.4 APAC Flutamide (CAS 13311-84-7) Sales Growth

4.5 Europe Flutamide (CAS 13311-84-7) Sales Growth

4.6 Middle East & Africa Flutamide (CAS 13311-84-7) Sales Growth

5 Americas

5.1 Americas Flutamide (CAS 13311-84-7) Sales by Country

5.1.1 Americas Flutamide (CAS 13311-84-7) Sales by Country (2017-2022)

5.1.2 Americas Flutamide (CAS 13311-84-7) Revenue by Country (2017-2022)

5.2 Americas Flutamide (CAS 13311-84-7) Sales by Type

5.3 Americas Flutamide (CAS 13311-84-7) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Flutamide (CAS 13311-84-7) Sales by Region

6.1.1 APAC Flutamide (CAS 13311-84-7) Sales by Region (2017-2022)

6.1.2 APAC Flutamide (CAS 13311-84-7) Revenue by Region (2017-2022)

6.2 APAC Flutamide (CAS 13311-84-7) Sales by Type

6.3 APAC Flutamide (CAS 13311-84-7) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Flutamide (CAS 13311-84-7) by Country

7.1.1 Europe Flutamide (CAS 13311-84-7) Sales by Country (2017-2022)

7.1.2 Europe Flutamide (CAS 13311-84-7) Revenue by Country (2017-2022)

7.2 Europe Flutamide (CAS 13311-84-7) Sales by Type

7.3 Europe Flutamide (CAS 13311-84-7) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Flutamide (CAS 13311-84-7) by Country

8.1.1 Middle East & Africa Flutamide (CAS 13311-84-7) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Flutamide (CAS 13311-84-7) Revenue by Country (2017-2022)

8.2 Middle East & Africa Flutamide (CAS 13311-84-7) Sales by Type

8.3 Middle East & Africa Flutamide (CAS 13311-84-7) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Flutamide (CAS 13311-84-7)

10.3 Manufacturing Process Analysis of Flutamide (CAS 13311-84-7)

10.4 Industry Chain Structure of Flutamide (CAS 13311-84-7)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Flutamide (CAS 13311-84-7) Distributors

11.3 Flutamide (CAS 13311-84-7) Customer

12 World Forecast Review for Flutamide (CAS 13311-84-7) by Geographic Region

12.1 Global Flutamide (CAS 13311-84-7) Market Size Forecast by Region

12.1.1 Global Flutamide (CAS 13311-84-7) Forecast by Region (2023-2028)

12.1.2 Global Flutamide (CAS 13311-84-7) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Flutamide (CAS 13311-84-7) Forecast by Type

12.7 Global Flutamide (CAS 13311-84-7) Forecast by Application

13 Key Players Analysis

13.1 Forward

13.1.1 Forward Company Information

13.1.2 Forward Flutamide (CAS 13311-84-7) Product Offered

13.1.3 Forward Flutamide (CAS 13311-84-7) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Forward Main Business Overview

13.1.5 Forward Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Flutamide (CAS 13311-84-7) Product Offered

13.2.3 Merck Flutamide (CAS 13311-84-7) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 Tasly Diyi Pharma

13.3.1 Tasly Diyi Pharma Company Information

13.3.2 Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Product Offered

13.3.3 Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Tasly Diyi Pharma Main Business Overview

13.3.5 Tasly Diyi Pharma Latest Developments

13.4 Cipla LifeScience

13.4.1 Cipla LifeScience Company Information

13.4.2 Cipla LifeScience Flutamide (CAS 13311-84-7) Product Offered

13.4.3 Cipla LifeScience Flutamide (CAS 13311-84-7) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Cipla LifeScience Main Business Overview

13.4.5 Cipla LifeScience Latest Developments

13.5 Actiza Pharma

13.5.1 Actiza Pharma Company Information

13.5.2 Actiza Pharma Flutamide (CAS 13311-84-7) Product Offered

13.5.3 Actiza Pharma Flutamide (CAS 13311-84-7) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Actiza Pharma Main Business Overview

13.5.5 Actiza Pharma Latest Developments

13.6 TEVA Pharma

13.6.1 TEVA Pharma Company Information

13.6.2 TEVA Pharma Flutamide (CAS 13311-84-7) Product Offered

13.6.3 TEVA Pharma Flutamide (CAS 13311-84-7) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 TEVA Pharma Main Business Overview

13.6.5 TEVA Pharma Latest Developments

13.7 Florencia Healthcare

13.7.1 Florencia Healthcare Company Information

13.7.2 Florencia Healthcare Flutamide (CAS 13311-84-7) Product Offered

13.7.3 Florencia Healthcare Flutamide (CAS 13311-84-7) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Florencia Healthcare Main Business Overview

13.7.5 Florencia Healthcare Latest Developments

13.8 SANDOZ

13.8.1 SANDOZ Company Information

13.8.2 SANDOZ Flutamide (CAS 13311-84-7) Product Offered

13.8.3 SANDOZ Flutamide (CAS 13311-84-7) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 SANDOZ Main Business Overview

13.8.5 SANDOZ Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Flutamide (CAS 13311-84-7) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Flutamide (CAS 13311-84-7) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Flutamide Tablets

Table 4. Major Players of Flutamide Capsule

Table 5. Major Players of Others

Table 6. Global Flutamide (CAS 13311-84-7) Sales by Type (2017-2022) & (Kg)

Table 7. Global Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2022)

Table 8. Global Flutamide (CAS 13311-84-7) Revenue by Type (2017-2022) & ($ million)

Table 9. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Type (2017-2022)

Table 10. Global Flutamide (CAS 13311-84-7) Sale Price by Type (2017-2022) & (USD/Kg)

Table 11. Global Flutamide (CAS 13311-84-7) Sales by Application (2017-2022) & (Kg)

Table 12. Global Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2022)

Table 13. Global Flutamide (CAS 13311-84-7) Revenue by Application (2017-2022)

Table 14. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Application (2017-2022)

Table 15. Global Flutamide (CAS 13311-84-7) Sale Price by Application (2017-2022) & (USD/Kg)

Table 16. Global Flutamide (CAS 13311-84-7) Sales by Company (2020-2022) & (Kg)

Table 17. Global Flutamide (CAS 13311-84-7) Sales Market Share by Company (2020-2022)

Table 18. Global Flutamide (CAS 13311-84-7) Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Company (2020-2022)

Table 20. Global Flutamide (CAS 13311-84-7) Sale Price by Company (2020-2022) & (USD/Kg)

Table 21. Key Manufacturers Flutamide (CAS 13311-84-7) Producing Area Distribution and Sales Area

Table 22. Players Flutamide (CAS 13311-84-7) Products Offered

Table 23. Flutamide (CAS 13311-84-7) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Flutamide (CAS 13311-84-7) Sales by Geographic Region (2017-2022) & (Kg)

Table 27. Global Flutamide (CAS 13311-84-7) Sales Market Share Geographic Region (2017-2022)

Table 28. Global Flutamide (CAS 13311-84-7) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Flutamide (CAS 13311-84-7) Sales by Country/Region (2017-2022) & (Kg)

Table 31. Global Flutamide (CAS 13311-84-7) Sales Market Share by Country/Region (2017-2022)

Table 32. Global Flutamide (CAS 13311-84-7) Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Flutamide (CAS 13311-84-7) Sales by Country (2017-2022) & (Kg)

Table 35. Americas Flutamide (CAS 13311-84-7) Sales Market Share by Country (2017-2022)

Table 36. Americas Flutamide (CAS 13311-84-7) Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Flutamide (CAS 13311-84-7) Revenue Market Share by Country (2017-2022)

Table 38. Americas Flutamide (CAS 13311-84-7) Sales by Type (2017-2022) & (Kg)

Table 39. Americas Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2022)

Table 40. Americas Flutamide (CAS 13311-84-7) Sales by Application (2017-2022) & (Kg)

Table 41. Americas Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2022)

Table 42. APAC Flutamide (CAS 13311-84-7) Sales by Region (2017-2022) & (Kg)

Table 43. APAC Flutamide (CAS 13311-84-7) Sales Market Share by Region (2017-2022)

Table 44. APAC Flutamide (CAS 13311-84-7) Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Flutamide (CAS 13311-84-7) Revenue Market Share by Region (2017-2022)

Table 46. APAC Flutamide (CAS 13311-84-7) Sales by Type (2017-2022) & (Kg)

Table 47. APAC Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2022)

Table 48. APAC Flutamide (CAS 13311-84-7) Sales by Application (2017-2022) & (Kg)

Table 49. APAC Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2022)

Table 50. Europe Flutamide (CAS 13311-84-7) Sales by Country (2017-2022) & (Kg)

Table 51. Europe Flutamide (CAS 13311-84-7) Sales Market Share by Country (2017-2022)

Table 52. Europe Flutamide (CAS 13311-84-7) Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Flutamide (CAS 13311-84-7) Revenue Market Share by Country (2017-2022)

Table 54. Europe Flutamide (CAS 13311-84-7) Sales by Type (2017-2022) & (Kg)

Table 55. Europe Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2022)

Table 56. Europe Flutamide (CAS 13311-84-7) Sales by Application (2017-2022) & (Kg)

Table 57. Europe Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Flutamide (CAS 13311-84-7) Sales by Country (2017-2022) & (Kg)

Table 59. Middle East & Africa Flutamide (CAS 13311-84-7) Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Flutamide (CAS 13311-84-7) Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Flutamide (CAS 13311-84-7) Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Flutamide (CAS 13311-84-7) Sales by Type (2017-2022) & (Kg)

Table 63. Middle East & Africa Flutamide (CAS 13311-84-7) Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Flutamide (CAS 13311-84-7) Sales by Application (2017-2022) & (Kg)

Table 65. Middle East & Africa Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Flutamide (CAS 13311-84-7)

Table 67. Key Market Challenges & Risks of Flutamide (CAS 13311-84-7)

Table 68. Key Industry Trends of Flutamide (CAS 13311-84-7)

Table 69. Flutamide (CAS 13311-84-7) Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Flutamide (CAS 13311-84-7) Distributors List

Table 72. Flutamide (CAS 13311-84-7) Customer List

Table 73. Global Flutamide (CAS 13311-84-7) Sales Forecast by Region (2023-2028) & (Kg)

Table 74. Global Flutamide (CAS 13311-84-7) Sales Market Forecast by Region

Table 75. Global Flutamide (CAS 13311-84-7) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Flutamide (CAS 13311-84-7) Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Flutamide (CAS 13311-84-7) Sales Forecast by Country (2023-2028) & (Kg)

Table 78. Americas Flutamide (CAS 13311-84-7) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Flutamide (CAS 13311-84-7) Sales Forecast by Region (2023-2028) & (Kg)

Table 80. APAC Flutamide (CAS 13311-84-7) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Flutamide (CAS 13311-84-7) Sales Forecast by Country (2023-2028) & (Kg)

Table 82. Europe Flutamide (CAS 13311-84-7) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Flutamide (CAS 13311-84-7) Sales Forecast by Country (2023-2028) & (Kg)

Table 84. Middle East & Africa Flutamide (CAS 13311-84-7) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Flutamide (CAS 13311-84-7) Sales Forecast by Type (2023-2028) & (Kg)

Table 86. Global Flutamide (CAS 13311-84-7) Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Flutamide (CAS 13311-84-7) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Flutamide (CAS 13311-84-7) Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Flutamide (CAS 13311-84-7) Sales Forecast by Application (2023-2028) & (Kg)

Table 90. Global Flutamide (CAS 13311-84-7) Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Flutamide (CAS 13311-84-7) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Flutamide (CAS 13311-84-7) Revenue Market Share Forecast by Application (2023-2028)

Table 93. Forward Basic Information, Flutamide (CAS 13311-84-7) Manufacturing Base, Sales Area and Its Competitors

Table 94. Forward Flutamide (CAS 13311-84-7) Product Offered

Table 95. Forward Flutamide (CAS 13311-84-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 96. Forward Main Business

Table 97. Forward Latest Developments

Table 98. Merck Basic Information, Flutamide (CAS 13311-84-7) Manufacturing Base, Sales Area and Its Competitors

Table 99. Merck Flutamide (CAS 13311-84-7) Product Offered

Table 100. Merck Flutamide (CAS 13311-84-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 101. Merck Main Business

Table 102. Merck Latest Developments

Table 103. Tasly Diyi Pharma Basic Information, Flutamide (CAS 13311-84-7) Manufacturing Base, Sales Area and Its Competitors

Table 104. Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Product Offered

Table 105. Tasly Diyi Pharma Flutamide (CAS 13311-84-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 106. Tasly Diyi Pharma Main Business

Table 107. Tasly Diyi Pharma Latest Developments

Table 108. Cipla LifeScience Basic Information, Flutamide (CAS 13311-84-7) Manufacturing Base, Sales Area and Its Competitors

Table 109. Cipla LifeScience Flutamide (CAS 13311-84-7) Product Offered

Table 110. Cipla LifeScience Flutamide (CAS 13311-84-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 111. Cipla LifeScience Main Business

Table 112. Cipla LifeScience Latest Developments

Table 113. Actiza Pharma Basic Information, Flutamide (CAS 13311-84-7) Manufacturing Base, Sales Area and Its Competitors

Table 114. Actiza Pharma Flutamide (CAS 13311-84-7) Product Offered

Table 115. Actiza Pharma Flutamide (CAS 13311-84-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 116. Actiza Pharma Main Business

Table 117. Actiza Pharma Latest Developments

Table 118. TEVA Pharma Basic Information, Flutamide (CAS 13311-84-7) Manufacturing Base, Sales Area and Its Competitors

Table 119. TEVA Pharma Flutamide (CAS 13311-84-7) Product Offered

Table 120. TEVA Pharma Flutamide (CAS 13311-84-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 121. TEVA Pharma Main Business

Table 122. TEVA Pharma Latest Developments

Table 123. Florencia Healthcare Basic Information, Flutamide (CAS 13311-84-7) Manufacturing Base, Sales Area and Its Competitors

Table 124. Florencia Healthcare Flutamide (CAS 13311-84-7) Product Offered

Table 125. Florencia Healthcare Flutamide (CAS 13311-84-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 126. Florencia Healthcare Main Business

Table 127. Florencia Healthcare Latest Developments

Table 128. SANDOZ Basic Information, Flutamide (CAS 13311-84-7) Manufacturing Base, Sales Area and Its Competitors

Table 129. SANDOZ Flutamide (CAS 13311-84-7) Product Offered

Table 130. SANDOZ Flutamide (CAS 13311-84-7) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)

Table 131. SANDOZ Main Business

Table 132. SANDOZ Latest Developments

List of Figures

Figure 1. Picture of Flutamide (CAS 13311-84-7)

Figure 2. Flutamide (CAS 13311-84-7) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Flutamide (CAS 13311-84-7) Sales Growth Rate 2017-2028 (Kg)

Figure 7. Global Flutamide (CAS 13311-84-7) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Flutamide (CAS 13311-84-7) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Flutamide Tablets

Figure 10. Product Picture of Flutamide Capsule

Figure 11. Product Picture of Others

Figure 12. Global Flutamide (CAS 13311-84-7) Sales Market Share by Type in 2021

Figure 13. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Type (2017-2022)

Figure 14. Flutamide (CAS 13311-84-7) Consumed in Hospital Pharmacies

Figure 15. Global Flutamide (CAS 13311-84-7) Market: Hospital Pharmacies (2017-2022) & (Kg)

Figure 16. Flutamide (CAS 13311-84-7) Consumed in Retail Pharmacies

Figure 17. Global Flutamide (CAS 13311-84-7) Market: Retail Pharmacies (2017-2022) & (Kg)

Figure 18. Flutamide (CAS 13311-84-7) Consumed in Online Pharmacies

Figure 19. Global Flutamide (CAS 13311-84-7) Market: Online Pharmacies (2017-2022) & (Kg)

Figure 20. Global Flutamide (CAS 13311-84-7) Sales Market Share by Application (2017-2022)

Figure 21. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Application in 2021

Figure 22. Flutamide (CAS 13311-84-7) Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Company in 2021

Figure 24. Global Flutamide (CAS 13311-84-7) Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Geographic Region in 2021

Figure 26. Global Flutamide (CAS 13311-84-7) Sales Market Share by Region (2017-2022)

Figure 27. Global Flutamide (CAS 13311-84-7) Revenue Market Share by Country/Region in 2021

Figure 28. Americas Flutamide (CAS 13311-84-7) Sales 2017-2022 (Kg)

Figure 29. Americas Flutamide (CAS 13311-84-7) Revenue 2017-2022 ($ Millions)

Figure 30. APAC Flutamide (CAS 13311-84-7) Sales 2017-2022 (Kg)

Figure 31. APAC Flutamide (CAS 13311-84-7) Revenue 2017-2022 ($ Millions)

Figure 32. Europe Flutamide (CAS 13311-84-7) Sales 2017-2022 (Kg)

Figure 33. Europe Flutamide (CAS 13311-84-7) Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Flutamide (CAS 13311-84-7) Sales 2017-2022 (Kg)

Figure 35. Middle East & Africa Flutamide (CAS 13311-84-7) Revenue 2017-2022 ($ Millions)

Figure 36. Americas Flutamide (CAS 13311-84-7) Sales Market Share by Country in 2021

Figure 37. Americas Flutamide (CAS 13311-84-7) Revenue Market Share by Country in 2021

Figure 38. United States Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Flutamide (CAS 13311-84-7) Sales Market Share by Region in 2021

Figure 43. APAC Flutamide (CAS 13311-84-7) Revenue Market Share by Regions in 2021

Figure 44. China Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Flutamide (CAS 13311-84-7) Sales Market Share by Country in 2021

Figure 51. Europe Flutamide (CAS 13311-84-7) Revenue Market Share by Country in 2021

Figure 52. Germany Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Flutamide (CAS 13311-84-7) Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Flutamide (CAS 13311-84-7) Revenue Market Share by Country in 2021

Figure 59. Egypt Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Flutamide (CAS 13311-84-7) Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Flutamide (CAS 13311-84-7) in 2021

Figure 65. Manufacturing Process Analysis of Flutamide (CAS 13311-84-7)

Figure 66. Industry Chain Structure of Flutamide (CAS 13311-84-7)

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390